Quantcast

Latest Temozolomide Stories

2013-09-30 14:19:00

Results from a clinical trial of a new treatment for glioblastoma suggest that researchers may have found a new approach to treating this most aggressive of brain tumors, as well as a potential new biological marker than can predict the tumor's response to treatment. Presenting the research to the 2013 European Cancer Congress (ECC2013) today (Monday), Professor Wolfgang Wick will say that combining radiotherapy with an anti-cancer drug called APG101 – a fusion protein similar to an...

2013-08-06 23:29:05

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new vaccine study beginning at North Shore-LIJ ‘s Brain Tumor Center. New York, NY (PRWEB) August 06, 2013 On August 6, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new vaccine study beginning at North Shore-LIJ’s Brain Tumor Center. According to an August 1, 2013 article published on The Island Now, titled, “Brain...

2013-06-03 10:45:11

The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center. The study was presented today on the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting by Mark Gilbert, M.D., professor in MD Anderson's Department of...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'